Identification of functional domains in the 14-kilodalton envelope protein (A27L) of vaccinia virus

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9098-9109

  Vázquez, María Isabel ^a   Esteban, Mariano ^a,b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CELL FUSION; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

EID: 0345411634     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9098-9109.1999     Document Type: Article

References (54)

1. Byrnes, A. P., and D. E. Griffin. 1998. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72:7349-7356.
2. Cardin, A. D., and H. J. R. Weintraub. 1998. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21-32.
3. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832.
4. Carr, C. M., and P. S. Kim. 1994. Flu virus invasion: halfway there. Science 246:234-236.
5. Chakrabarti, S., J. R. Sisler, and B. Moss. 1997. Compact, synthetic, vaccinia virus early/late promoter for protein expression. BioTechniques 23:1094-1097.
6. Chan, D. C., D. Fass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
7. Chen, Y., R. E. Maguire, R E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, and R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
8. Chung, C.-S., J.-C. Hsiao, Y.-S. Chang, and W. Chang. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72:1577-1585.
9. Demkowicz, W. E., J. S. Maa, and M. Esteban. 1992. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J. Virol. 66:386-398.
10. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
11. Doms, R. W., R. Blumenthal, and B. Moss. 1990. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64: 4884-4892.
12. D'Souza, M. P., and V. A. Harden. 1996. Chemokines and HIV-1 second receptors. Nat. Med. 2:1293-1300.
13. Esteban, M. 1984. Defective vaccinia virus particles in interferon-treated infected cells. Virology 133:220-227.
14. Fass, D., S. C. Harrison, and P. S. Kim. 1996. Structure of Moloney murine virus envelope domain at 1.7Å resolution. Nat. Struct. Biol. 3:465-469.
15. Flynn, S. J., and P. Ryan. 1996. The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant. J. Virol. 70:1355-1364.
16. r envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus. J. Virol. 63:4507-4514.
17. Gong, S. C., C. Lai, and M. Esteban. 1990. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 178:81-91.
18. Herold, B. C., D. WuDunn, N. Soltys, and P. G. Spear. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1090-1098.
19. Hiller, G., and K. Weber. 1985. Golgi-derived membranes that contain an acylated viral polypeplide are used for vaccinia virus envelopment. J. Virol. 55:651-659.
20. Hsiao, J.-C., C.-S. Chung, and W. Chang. 1998. Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding protein. J. Virol. 72:8374-8379.
21. Ichihashi, Y. 1996. Extracellular enveloped vaccinia virus escapes neutralization. Virology 217:478-485.
22. Ichihashi, Y., S. Matsumoto, and S. Dales. 1971. Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology 46:507-532.
23. Ichihashi, Y., T. Takahashi, and M. Oie. 1994. Identification of a vaccinia virus penetration protein. Virology 202:834-843.
24. Jackson, T., F. M. Ellard, R. A. Ghazaleh, S. M. Brookes, W. E. Blakemore, A. H. Corteyn, D. I. Stuart, J. W. Newman, and A. M. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-5287.
25. Joklik, W. K. 1962. The purification of four strains of poxvirus. Virology 18:9-18.
26. Kjellén, L., and U. Lindahl. 1991. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:443-475.
27. Klimstra, W. B., K. D. Ryman, and R. E. Johnston. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
28. Krusat, T., and H.-J. Streckert. 1997. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142:1247-1254.
29. Lai, C., S. Gong, and M. Esteban. 1990. Structural and functional properties of 14kDa envelope protein of vaccinia virus synthesized in Escherichia coli. J. Biol. Chem. 265:22174-22180.
30. Laquerre, S., R. Argnani, D. B. Anderson, S. Zucchini, R. Manservigi, and J. C. Glorioso. 1998. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J. Virol. 72:6119-6130.
31. Meyer, H., N. Osterrieder, and C.-P. Czerny. 1994. Identification of binding sites for neutralizing monoclonal antibodies on the 14-kDa fusion protein of orthopox viruses. Virology 200:778-783.
32. Morgan, C. 1976. Vaccinia virus reexamined: development and release. Virology 73:43-58.
33. Rodriguez, D., J.-R. Rodriguez, and M. Esteban. 1993. The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J. Virol. 67:3435-3440.
34. Rodriguez, J. F., R. Janezcko, and M. Esteban. 1985. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J. Virol. 56:482-488.
35. r envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J. Virol. 61:395-404.
36. Rodriguez, J. F., and G. L. Smith. 1990. Inducible gene expression from vaccinia virus vectors. Virology 177:239-250.
37. Rodriguez, J. F., and G. L. Smith. 1990. IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res. 18:5347-5351.
38. Roos, N., M. Cyrklaff, S. Cudmore, R. Blasco, J. Krijnse Locker, and G. Griffiths. 1996. A novel immunogold cryo EM method to investigate the structure of IMV/EEV. EMBO J. 15:2343-2355.
39. Sattentau, Q. J., and R. A. Weiss. 1991. The CD4 antigen: physiological ligand and HIV receptor. Cell 52:631-633.
40. Schmelz, M., B. Sodeik, M. Ericsson, E. J. Wolffe, H. Shida, G. Hiller, and G. Griffiths. 1994. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68:130-147.
41. Sheih, M., R. I. Montgomery, J. D. Esko, and P. Spear. 1992. Cell surface receptors for herpex simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1273-1281.
42. Sodeik, B., R. W. Doms, M. Ericsson, G. Hiller, C. E. Machamer, W. van't Hof, G. van Meer, B. Moss, and G. Griffiths. 1993. Assembly of vaccinia virus: role of intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J. Cell Biol. 121:521-541.
43. Sodeik, B., S. Cudmore, M. Ericsson, M. Esteban, E. G. Niles, and G. Griffiths. 1995. Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J. Virol. 69:3560-3574.
44. Summerford, C., and R. J. Samulski. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
45. Turner, P. C., and R. W. Moyer. 1992. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. J. Virol. 66:2076-2085.
46. Vanderplasschen, A., and G. L. Smith. 1997. A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J. Virol. 71:4032-4041.
47. Vanderplasschen, A., M. Hollinshead, and G. L. Smith. 1998. Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J. Gen. Virol. 79:877-887.
48. Vázquez, M.-I., G. Rivas, D. Cregut, L. Serrano, and M. Esteban. 1998. The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal α-helix. J. Virol. 72:10126-10137.
49. Weissenhorn, W., A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
50. White, J. M. 1990. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:675-697.
51. White, J. M. 1992. Membrane fusion. Science 258:917-924.
52. Wolffe, E. J., S. Vijaya, and B. Moss. 1995. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology 211:53-63.
53. WuDunn, D., and D. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
54. Yu, Y. G., D. S. King, and Y.-K. Shin. 1994. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science 266:274-276.